Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, is pleased to announce that the audit of its accounts for the year ended 31 March 2019 is now proceeding.
Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, notes that Paraytec Limited (“Paraytec”) has announced that it has engaged an adviser to raise £4 million of equity fundraising in order to fund the further development, regulatory approval and commercialisation of its innovative urine test for the detection and monitoring of bladder cancer.
Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, is pleased to give the following update on trading ahead of its final results for the year ended 31 March 2018, which will be released on 19 June 2018.